publicado em Notícias
12/09/2014
Os autores (Wenhui Zhao, Jing Guan, Ronald Horswell, Weiqin Li, Yujie Wang, Xiaocheng Wu e Gang Hu) tinham como objetivo de investigar a relação entre o colesterol HDL (HDL-C) e o risco de cancro em doentes com diabetes tipo 2(DM2).
Continue reading “Colesterol HDL e risco de cancro em doentes com diabetes tipo 2”
publicado em Notícias
14/07/2014
O INFARMED emitiu uma Circular Informativa N.º 092/CD/8.1.7. a 11/04/2014 com Recomendações de utilização dos fármacos Modificadores do eixo renina angiotensina:
publicado em Notícias
01/04/2014
Growth differentiation factor 15 (GDF-15) is a relatively new biomarker that predicts mortality in patients with chronic stable angina or acute coronary syndrome. However, the association of GDF-15 with cardiovascular (CV) events and the mechanisms of this association are not well understood.
publicado em Notícias
01/04/2014
Studies of prehypertension and mortality are controversial after adjusting for other cardiovascular risk factors. This meta-analysis sought to evaluate the association of prehypertension with all-cause and cardiovascular disease (CVD) mortality.
publicado em Notícias
01/04/2014
To derive and validate a clinical rule that stratifies the risk of cardiac complications in patients hospitalized for community-acquired pneumonia (CAP) and compare its performance to the pneumonia severity index (PSI) score.
publicado em Notícias
01/04/2014
To examine 18-year trends in short-term and long-term stroke mortality and the prognostic influence of comorbidity.
publicado em Notícias
01/04/2014
Nonsteroidal anti-inflammatory drugs (NSAIDs) other than aspirin have been linked to heart failure, salt retention, adverse ventricular remodeling, and thrombosis. We therefore sought to assess their impact on cardiovascular events in outpatients with stable atherothrombotic disease.
publicado em Notícias
06/02/2014
A Sociedade Internacional de Aterosclerose (IAS) atualizou as suas recomendações sobre o tratamento da hipercolesterolemia e dislipidemias para reduzir o risco de doença cardiovascular aterosclerótica (ASCVD) em Dezembro 2013.
Continue reading “A Sociedade Internacional de Aterosclerose (IAS) atualizou as suas recomendações”
publicado em Notícias
01/10/2013
Aims: The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (FH) is underdiagnosed and undertreated. The second aim was to provide guidance for screening and treatment of FH, in order to prevent coronary heart disease.
